Pfizer MVC 150 (Selzentry 150 mg)
Generic Name: maraviroc
Pill imprint Pfizer MVC 150 has been identified as Selzentry 150 mg.
Selzentry is used in the treatment of hiv infection and belongs to the drug class chemokine receptor antagonist. There is no proven risk in humans during pregnancy. Selzentry 150 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for Pfizer MVC 150
- Generic Name:
- 150 mg
- 12.00 mm
- Elliptical / Oval
- Prescription only
- Drug Class:
- Chemokine receptor antagonist
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- N - Not a controlled drug
- Pfizer U.S. Pharmaceuticals Group
- National Drug Code (NDC):
- Inactive Ingredients:
- microcrystalline cellulose
calcium phosphate dibasic anhydrous
sodium starch glycolate type A potato
FD&C Blue No. 2
|NDC Code||Manufacturer / Repackager|
|35356-0208||Lake Erie Medical and Surgical Supply (repackager)|
|54569-6143||A S Medication Solutions LLC (repackager)|
Note: Inactive ingredients may vary.
More about Selzentry (maraviroc)
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.